文献速递产科

在马萨诸塞州队列中,分娩时获取毒理学检测的知情同意记录不充分

Informed consent is poorly documented when obtaining toxicology testing at delivery in a Massachusetts cohort.
PubMed 文献 · Am J Obstet Gynecol MFM · 2022-03-27

该回顾性队列纳入2016年4月至2020年4月马萨诸塞州5家附属医院分娩后96小时内接受毒理学检测的个体,评估临床医生对患者同意的记录情况。1562例检测中仅466例(29.8%)记录了口同意,有同意政策的医院记录同意的比值比为2.10(95%CI 1.01-4.37),结论认为同意获取不频繁,需要提供者教育和医院政策。

要点

  • 分娩时毒理学检测记录口同意的比例为29.8%(466/1562)。
  • 有同意政策的医院记录口同意的比值比为2.10(95%CI 1.01-4.37)。
  • 以产科并发症为检测指征时记录同意的比值比为0.46(95%CI 0.28-0.76)。

核心结论

  • 基于临床医生记录,分娩时毒理学检测的同意似乎不常获取。
  • 需要提供者教育和医院政策来获取知情同意,以保护分娩个体的权利。

研究设计与样本

  • 回顾性队列研究,纳入2016年4月至2020年4月在马萨诸塞州5家附属医院分娩后96小时内接受毒理学检测的个体。
  • 共60718例分娩中获取了1562例产妇毒理学检测,审查病历记录临床医生意图、检测指征、口同意和儿童保护服务介入。
  • 采用分层多变量logistic回归分析患者和医院特征与口同意记录的关联。

主要发现

  • 1562例产妇毒理学检测中,466例(29.8%)记录了口同意。
  • 大多数人口学组别中均缺乏同意记录。
  • 向儿童保护服务提交报告时,同意记录的可能性并未更高;在分娩父母出院前失去监护权的病例中,同意记录的可能性更低(P=.003)。
  • 多变量模型中,以产妇并发症(胎盘早剥、高血压、早产、未足月胎膜早破或宫内胎儿死亡)为检测指征时,同意记录的可能性最低(调整比值比0.46;95%置信区间0.28-0.76)。
  • 在已制定同意政策的接产医院,记录口同意的可能性是两倍(调整比值比2.10;95%置信区间1.01-4.37)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Positive toxicology testing at delivery can have enormous consequences for birthing persons and their families, including charges of child abuse or neglect and potential loss of custody for the birthing parent. Therefore state and national guidelines stipulate that, clinicians must obtain consent before toxicology testing at delivery. OBJECTIVE: This study aimed (1) to determine clinician documentation of patient consent for peripartum toxicology testing and (2) to characterize the extent to which patient and hospital characteristics were associated with documented consent. STUDY DESIGN: This was a retrospective cohort of individuals who underwent toxicology testing within 96 hours of delivery between April 2016 and April 2020 at 5 affiliated hospitals across Massachusetts. Medical records were reviewed for documentation of clinician intent to obtain maternal toxicology, testing indication, verbal consent to testing, and child protective services involvement. Hierarchical multivariable logistic regression was used to examine the association between patient and hospital characteristics and documentation of verbal consent. RESULTS: Among 60,718 deliveries, 1562 maternal toxicology tests were obtained. Verbal consent for testing was documented in 466 cases (29.8%). Documented consent was lacking across most demographic groups. Consent was no more likely to be documented when a report was filed with child protective services and less likely in cases where the birthing parent lost custody before discharge (P=.003). In our multivariable model, consent was least likely to be documented when a maternal complication (abruption, hypertension, preterm labor, preterm premature rupture of membranes, or intrauterine fetal demise) was the indication for testing (adjusted odds ratio, 0.46; 95% confidence interval, 0.28-0.76). Verbal consent was twice as likely to be documented in delivery hospitals with established consent policies (adjusted odds ratio, 2.10; 95% confidence interval, 1.01-4.37). CONCLUSION: Consent for toxicology testing at delivery seemed to be infrequently obtained on the basis of clinician documentation. Provider education and hospital policies for obtaining informed consent are needed to protect the rights of birthing individuals.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Koenigs KJ, Chou JH, Cohen S, et al. Informed consent is poorly documented when obtaining toxicology testing at delivery in a Massachusetts cohort. Am J Obstet Gynecol MFM. 2022. PMID: 35354087. doi:10.1016/j.ajogmf.2022.100621

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。